CLGN
Price
$3.50
Change
-$0.04 (-1.13%)
Updated
Sep 11 closing price
Capitalization
6.62M
80 days until earnings call
Intraday BUY SELL Signals
CLLS
Price
$3.10
Change
+$0.05 (+1.64%)
Updated
Sep 11 closing price
Capitalization
307.99M
57 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CLGN vs CLLS

CLGN vs CLLS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CLGN vs. CLLS commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLGN is a Hold and CLLS is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLLS($308M) has a higher market cap than CLGN($6.62M). CLLS YTD gains are higher at: -35.950 vs. CLGN (-75.000). CLGN has higher annual earnings (EBITDA): -12.07M vs. CLLS (-38.52M). CLLS has more cash in the bank: 167M vs. CLGN (2.84M). CLGN has less debt than CLLS: CLGN (2.65M) vs CLLS (84.6M). CLLS has higher revenues than CLGN: CLLS (56.6M) vs CLGN (389K).
CLGNCLLSCLGN / CLLS
Capitalization6.62M308M2%
EBITDA-12.07M-38.52M31%
Gain YTD-75.000-35.950209%
P/E RatioN/AN/A-
Revenue389K56.6M1%
Total Cash2.84M167M2%
Total Debt2.65M84.6M3%
FUNDAMENTALS RATINGS
CLGN vs CLLS: Fundamental Ratings
CLGN
CLLS
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
45
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
6352
P/E GROWTH RATING
1..100
2100
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLLS's Valuation (45) in the Biotechnology industry is somewhat better than the same rating for CLGN (99). This means that CLLS’s stock grew somewhat faster than CLGN’s over the last 12 months.

CLLS's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CLGN (100). This means that CLLS’s stock grew similarly to CLGN’s over the last 12 months.

CLLS's SMR Rating (98) in the Biotechnology industry is in the same range as CLGN (99). This means that CLLS’s stock grew similarly to CLGN’s over the last 12 months.

CLLS's Price Growth Rating (52) in the Biotechnology industry is in the same range as CLGN (63). This means that CLLS’s stock grew similarly to CLGN’s over the last 12 months.

CLGN's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for CLLS (100). This means that CLGN’s stock grew significantly faster than CLLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLGNCLLS
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
68%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 13 days ago
81%
Bullish Trend 24 days ago
78%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
61%
COMPARISON
Comparison
Sep 13, 2026
Stock price -- (CLGN: $3.50 vs. CLLS: $3.10)
Brand notoriety: CLGN and CLLS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLGN: 30% vs. CLLS: 484%
Market capitalization -- CLGN: $6.62M vs. CLLS: $307.99M
CLGN [@Biotechnology] is valued at $6.62M. CLLS’s [@Biotechnology] market capitalization is $307.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLGN’s FA Score shows that 1 FA rating(s) are green while CLLS’s FA Score has 0 green FA rating(s).

  • CLGN’s FA Score: 1 green, 4 red.
  • CLLS’s FA Score: 0 green, 5 red.
According to our system of comparison, both CLGN and CLLS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLGN’s TA Score shows that 5 TA indicator(s) are bullish while CLLS’s TA Score has 5 bullish TA indicator(s).

  • CLGN’s TA Score: 5 bullish, 5 bearish.
  • CLLS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both CLGN and CLLS are a good buy in the short-term.

Price Growth

CLGN (@Biotechnology) experienced а -1.41% price change this week, while CLLS (@Biotechnology) price change was -4.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

CLGN is expected to report earnings on Dec 02, 2026.

CLLS is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CLGN
Daily Signal:
Gain/Loss:
CLLS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CALM73.980.27
+0.37%
Cal-Maine Foods
BNTX96.730.33
+0.34%
BioNTech SE American Depositary Share
AHG0.74-0.01
-1.70%
Akso Health Group ADS
FFAI1.67-0.04
-2.34%
Faraday Future Intelligent Electric Inc.
MIST0.98-0.07
-6.66%
Milestone Pharmaceuticals

CLGN and

Correlation & Price change

A.I.dvisor tells us that CLGN and CLLS have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLGN and CLLS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLGN
1D Price
Change %
CLGN100%
-1.13%
CLLS - CLGN
33%
Poorly correlated
+1.64%
SPRO - CLGN
30%
Poorly correlated
+0.89%
ACET - CLGN
26%
Poorly correlated
-0.10%
ALZN - CLGN
26%
Poorly correlated
+1.18%
VOR - CLGN
25%
Poorly correlated
-0.18%
More

CLLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLLS has been loosely correlated with SLN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CLLS jumps, then SLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLLS
1D Price
Change %
CLLS100%
+1.64%
SLN - CLLS
43%
Loosely correlated
-2.18%
MDGL - CLLS
40%
Loosely correlated
+0.26%
PMVP - CLLS
38%
Loosely correlated
-2.78%
AXON - CLLS
36%
Loosely correlated
+0.10%
TGTX - CLLS
36%
Loosely correlated
-2.71%
More